Matsuba H M, Thawley S E, Devineni V R, Levine L A, Smith P G
Laryngoscope. 1985 Sep;95(9 Pt 1):1059-63.
The trend toward treatment of parotid gland malignancies with planned combined surgery and postoperative radiation therapy is currently being followed by many centers, although prospective studies confirming the efficacy of this treatment regimen have only recently begun. We have reviewed only our "high-grade" histologic types: adenocarcinomas, malignant mixed tumors, high-grade mucoepidermoid carcinomas, squamous cell carcinomas, and undifferentiated carcinomas. Acinic cell carcinomas, adenoid cystic carcinomas, and low-grade mucoepidermoid carcinomas were excluded from study because of their different biologic behavior. Since 1974, we have employed the approach of surgical extirpation with preservation of the facial nerve when possible for all parotid tumors, combined with planned postoperative radiation therapy (50-70 Gy). We reviewed the 37 cases of "high-grade" parotid gland malignancies and compared the patients treated with the combined modality approach with our historical patients treated initially with surgery alone. Despite an apparent higher stage at presentation, our combined treatment group ultimately had significantly better local control (70% vs. 20%), and an equivalent survival rate at five years. Tumor was present at the margin of resection in 14 (74%) cases treated with combined surgery and irradiation. The facial nerve was preserved in six of these patients with positive margins, and only one of these patients developed a local or regional treatment failure. In conclusion, our data confirms the efficacy of surgical exploration to determine the extent of disease and surgical resection, preserving facial nerve function if possible, followed by postoperative radiation therapy at adequate doses. Control of local-regional disease was much improved by combined modality therapy as opposed to surgical resection alone, despite the prevalence of residual microscopic disease in the resection margins. Facial nerve function is optimally preserved by this approach of conservative surgery combined with postoperative radiation therapy.
目前,许多中心都在采用计划性联合手术及术后放射治疗的方法来治疗腮腺恶性肿瘤,尽管证实这种治疗方案有效性的前瞻性研究直到最近才开始。我们仅回顾了“高级别”组织学类型:腺癌、恶性混合瘤、高级别黏液表皮样癌、鳞状细胞癌和未分化癌。腺泡细胞癌、腺样囊性癌和低级别黏液表皮样癌因其不同的生物学行为而被排除在研究之外。自1974年以来,对于所有腮腺肿瘤,我们都采用尽可能保留面神经的手术切除方法,并结合计划性术后放射治疗(50 - 70 Gy)。我们回顾了37例“高级别”腮腺恶性肿瘤病例,并将接受联合治疗方法的患者与我们最初仅接受手术治疗的历史患者进行了比较。尽管就诊时分期明显较高,但我们的联合治疗组最终局部控制效果显著更好(70%对20%),且五年生存率相当。在接受联合手术和放疗的14例(74%)病例中,切除边缘有肿瘤残留。在这些切缘阳性的患者中,6例保留了面神经,其中只有1例出现局部或区域治疗失败。总之,我们的数据证实了手术探查以确定疾病范围和进行手术切除的有效性,尽可能保留面神经功能,随后给予足够剂量的术后放射治疗。与单纯手术切除相比,联合治疗显著改善了局部区域疾病的控制,尽管切除边缘存在残留微小疾病。通过这种保守手术联合术后放射治疗的方法,面神经功能得到了最佳保留。